Cargando…

Evaluation of potentially inappropriate medications use and medication complexity in elderly patients applying to community pharmacy in Turkey

BACKGROUND: Older adults often use multiple medicines to manage comorbidities well or to prevent associated complications. This study aims to determine polypharmacy, the use of potentially inappropriate medications (PIMs) using the 2019 Beers Criteria and to determine the Medication Regimen Complexi...

Descripción completa

Detalles Bibliográficos
Autores principales: Albayrak, Aslınur, Demirbaş, Halil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571236/
https://www.ncbi.nlm.nih.gov/pubmed/37833671
http://dx.doi.org/10.1186/s12877-023-04381-4
_version_ 1785119943072677888
author Albayrak, Aslınur
Demirbaş, Halil
author_facet Albayrak, Aslınur
Demirbaş, Halil
author_sort Albayrak, Aslınur
collection PubMed
description BACKGROUND: Older adults often use multiple medicines to manage comorbidities well or to prevent associated complications. This study aims to determine polypharmacy, the use of potentially inappropriate medications (PIMs) using the 2019 Beers Criteria and to determine the Medication Regimen Complexity Index (MRCI) score. It also aims to identify factors associated with the presence of PIMs and the MRCI score. METHODS: This cross-sectional study was carried out between 6 and 2023 and 5 May 2023 in a community pharmacy in Turkey. Elderly patients over 65 years of age, who used at least one drug, and who came to the pharmacy for any reason were included in the study. PIMs were determined according to the 2019 Beers Criteria. The Turkish validated version of the MRCI was used to determine the medication complexity score. RESULTS: 200 patients were included in this study. 59.5% of the patients were female and the median age was 70 (IQR, 66-74.75). Polypharmacy was detected in 33% of patients. The use of PIMs was determined in 63.5% of the patients. The median of the MRCI score was 11 (IQR, 7–15). The number of chronic diseases and drugs, presence of polypharmacy, MRCI score and mental disorders were found to be significantly higher in those with PIMs than in those without (p < 0.05). Having less than eight years of education, presence of polypharmacy, the presence of comorbidity (diabetes mellitus, cardiovascular disease, thyroid, chronic obstructive pulmonary disease (COPD), asthma and mental disorders) were associated with significantly higher MRCI scores (p < 0.05). CONCLUSIONS: According to the results of our study, it was found that the elderly patients who came to the pharmacy had low MRCI scores, but had high PIMs use. Community pharmacists have an important role in identifying inappropriate drug use, so they should be trained to develop skills in identifying and reducing PIMs in older patients.
format Online
Article
Text
id pubmed-10571236
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105712362023-10-14 Evaluation of potentially inappropriate medications use and medication complexity in elderly patients applying to community pharmacy in Turkey Albayrak, Aslınur Demirbaş, Halil BMC Geriatr Research BACKGROUND: Older adults often use multiple medicines to manage comorbidities well or to prevent associated complications. This study aims to determine polypharmacy, the use of potentially inappropriate medications (PIMs) using the 2019 Beers Criteria and to determine the Medication Regimen Complexity Index (MRCI) score. It also aims to identify factors associated with the presence of PIMs and the MRCI score. METHODS: This cross-sectional study was carried out between 6 and 2023 and 5 May 2023 in a community pharmacy in Turkey. Elderly patients over 65 years of age, who used at least one drug, and who came to the pharmacy for any reason were included in the study. PIMs were determined according to the 2019 Beers Criteria. The Turkish validated version of the MRCI was used to determine the medication complexity score. RESULTS: 200 patients were included in this study. 59.5% of the patients were female and the median age was 70 (IQR, 66-74.75). Polypharmacy was detected in 33% of patients. The use of PIMs was determined in 63.5% of the patients. The median of the MRCI score was 11 (IQR, 7–15). The number of chronic diseases and drugs, presence of polypharmacy, MRCI score and mental disorders were found to be significantly higher in those with PIMs than in those without (p < 0.05). Having less than eight years of education, presence of polypharmacy, the presence of comorbidity (diabetes mellitus, cardiovascular disease, thyroid, chronic obstructive pulmonary disease (COPD), asthma and mental disorders) were associated with significantly higher MRCI scores (p < 0.05). CONCLUSIONS: According to the results of our study, it was found that the elderly patients who came to the pharmacy had low MRCI scores, but had high PIMs use. Community pharmacists have an important role in identifying inappropriate drug use, so they should be trained to develop skills in identifying and reducing PIMs in older patients. BioMed Central 2023-10-13 /pmc/articles/PMC10571236/ /pubmed/37833671 http://dx.doi.org/10.1186/s12877-023-04381-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Albayrak, Aslınur
Demirbaş, Halil
Evaluation of potentially inappropriate medications use and medication complexity in elderly patients applying to community pharmacy in Turkey
title Evaluation of potentially inappropriate medications use and medication complexity in elderly patients applying to community pharmacy in Turkey
title_full Evaluation of potentially inappropriate medications use and medication complexity in elderly patients applying to community pharmacy in Turkey
title_fullStr Evaluation of potentially inappropriate medications use and medication complexity in elderly patients applying to community pharmacy in Turkey
title_full_unstemmed Evaluation of potentially inappropriate medications use and medication complexity in elderly patients applying to community pharmacy in Turkey
title_short Evaluation of potentially inappropriate medications use and medication complexity in elderly patients applying to community pharmacy in Turkey
title_sort evaluation of potentially inappropriate medications use and medication complexity in elderly patients applying to community pharmacy in turkey
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571236/
https://www.ncbi.nlm.nih.gov/pubmed/37833671
http://dx.doi.org/10.1186/s12877-023-04381-4
work_keys_str_mv AT albayrakaslınur evaluationofpotentiallyinappropriatemedicationsuseandmedicationcomplexityinelderlypatientsapplyingtocommunitypharmacyinturkey
AT demirbashalil evaluationofpotentiallyinappropriatemedicationsuseandmedicationcomplexityinelderlypatientsapplyingtocommunitypharmacyinturkey